Download

Download Full Text (461 KB)

Document Type

Poster

Description

• First line treatment of cardiovascular disease is lifestyle modification followed by the pharmacologic intervention of HMG-CoA reductase inhibitors or statins

• Statins are commonly associated with intolerable side effects such as myalgia leading to medication non-compliance

• RYR preparations claim to inhibit cholesterol synthesis without causing myalgia

• RYR preparations have naturally occurring monacolins such as monacolin K which is chemically identical to lovastatin

• RYR is not regulated by the FDA leading to questionable manufacturing practices producing varying ingredient composition

• The purpose of this study is to investigate the role RYR in hyperlipidemia treatment compared to statins by evaluating efficacy, side effects, and the potential to reduce medication non-compliance in adults

• Clinicians potentially could recommend RYR as an alternative treatment to hyperlipidemia in patients unable to comply with statin treatment to decrease cholesterol levels and reduce the progression of atherosclerosis

Department

Physician Assistant Studies

Degree Name

Master of Physician Assistant Studies (MPAS)

Publication Date

2014

Keywords

Atherosclerosis -- drug therapy; Complementary Therapies; Hydroxymethylglutaryl-CoA Reductase Inhibitors -- therapeutic use; Hyperlipidemias -- drug therapy; Treatment Adherence and Compliance; Comparative Study

Disciplines

Alternative and Complementary Medicine | Cardiovascular Diseases

Alternative Treatment with Red Yeast Rice to Reduce Hyperlipidemia

Share

COinS